Clinical evaluation of deep learning-based risk profiling in breast cancer histopathology and comparison to an established multigene assay.

MLA

Wang, Yinxi, et al. “Clinical Evaluation of Deep Learning-Based Risk Profiling in Breast Cancer Histopathology and Comparison to an Established Multigene Assay.” Breast Cancer Research and Treatment, vol. 206, no. 1, July 2024, pp. 163–75. EBSCOhost, https://doi.org/10.1007/s10549-024-07303-z.

APA

Wang, Y., Sun, W., Karlsson, E., Kang Lövgren, S., Ács, B., Rantalainen, M., Robertson, S., & Hartman, J. (2024). Clinical evaluation of deep learning-based risk profiling in breast cancer histopathology and comparison to an established multigene assay. Breast Cancer Research and Treatment, 206(1), 163–175. https://doi.org/10.1007/s10549-024-07303-z

Chicago

Wang, Yinxi, Wenwen Sun, Emelie Karlsson, Sandy Kang Lövgren, Balázs Ács, Mattias Rantalainen, Stephanie Robertson, and Johan Hartman. 2024. “Clinical Evaluation of Deep Learning-Based Risk Profiling in Breast Cancer Histopathology and Comparison to an Established Multigene Assay.” Breast Cancer Research and Treatment 206 (1): 163–75. doi:10.1007/s10549-024-07303-z.